Present knowledge about syncarcinogenesis in exogenously induced tumors;Neue Erkenntnisse zur Synkanzerogenese bei exogen verursachten Tumoren

Zentralblatt fur Hygiene und Umweltmedizin

Volumn 198, Issue 5, 1996, Pages 407-428

  Popp, Walter ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Inst F Hygiene Und Arbeitsmedizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

AIR POLLUTANT; ANIMAL; CARCINOGEN TESTING; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; EXPERIMENTAL NEOPLASM; HUMAN; NEOPLASM; OCCUPATIONAL DISEASE; REVIEW; RISK FACTOR;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS, ENVIRONMENTAL; COCARCINOGENESIS; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; OCCUPATIONAL DISEASES; RISK FACTORS;

EID: 0030132501     PISSN: 09348859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Aguilar, R., S. P. Hussain, and P. Cerutti: Aflatoxin Bl induces thé transversion of G->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Nad. Acad. Sci. USA 90 (1993) 8586-8590
2. Anderson, L. M., V. L. Souliotis, J. M. Rice, and S. A. Kyrtopoulos: Enhancement of O6-methylguanine in blood cells of patas monkeys by cotreatment of ethanol with Nnitrosodimethylamine. Proc. Am. Assoc. Cancer Res. 35 (1994) 139
3. Anwar, K, H. Naiki, K. Nakakuki, and M. Inuzuka: High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70 (1992) 1967-1973
4. Armstrong, B., C. Tremblay, D. Baris, and G. Thériault: Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminium production workers in Arvida, Quebec, Canada. Am. J. Epidemiol. 139 (1994) 250-262
5. Autrup, J. L., C. Hansen, and H. Autrup: Detection of tobacco smoke carcinogen-DNA adducts in cultured rat buccal mucosa cells following exposure to ethanol and total cigarette smoke condensate or chewing tobacco. Chem.-Biol. Interact. 85 (1992) HI150
6. Baarson, K. A., C. A. Snyder, J. D. Green, A. Sellakumar, B. D. Goldstein, and R. E. Albert: The hematotoxic effects of inhaled benzene on peripheral blood, bone marrow, and spleen cells are increased by ingested ethanol. Toxicol. Appl. Pharmacol. 64 (1982) 393-404
7. Bi, W., R. B. Hayes, P. Feng, Y. Qi, X. You,}. Zhen, M. Zhang, B. Qu, Z. Fu, M. Chen, H. T. C. Chien, and W. J. Blot: Mortality and incidence of bladder cancer in benzidineexposed workers in China. Am. J. Ind. Med. 21 (1992) 481-489
8. BIA: BIA-Handbuch. St. Augustin 1995
9. Blaser, M. J., P. H. Chyou, and A.Nomura: Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 55 (1995)562-565
10. Blattner, W. A.: Human retroviruses and malignancy. In: Brugge, J., T. Curran, E. Harlow, and E McCormick (eds.): Origins of human cancer: a comprehensive review. Cold Spring Harbor Laboratory Press 1991, 199-209
11. Bolm-Audorf, U., K.-H. Jockei, B. Kilguss, H. Pohlabeln und T. Siepenkotken: Bösartige Tumoren der ableitenden Harnwege und Risiken am Arbeitsplatz. Schriftenreihe der Bundesanstalt für Arbeitsschutz. Fb 697. Dortmund 1993
12. Brachmann, D. G., D. Graves, E. Vokes, M. Beckett, D. Haraf, A. Montag, E. Dunphy, R. Mich, D. Yandell, and R. R. Weichselbaum: Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 52 (1992) 4832-4836
13. Bressac, B., M. Kew, J. Wands, and M. Ozturk: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350 (1991) 429-431
14. Caporaso, N., R. B. Hayes, M. Dosemeci, R. Hoover, R. Ayesh, M. Hetzel, andJ. Idle: Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res. 49 (1989) 3675-3679
15. Carbone, M., H. 1. Pass, P. Rizzo, M. Marinetti, M. di Muzio, D. J. Y. Mew, A. S. Levine, and A. Procopio: Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9 (1994) 1781-1790
16. Cartwrigth, R.: Occupational bladder cancer and cigarette smoking in West Yorkshire. Scand. J. Work Environ. Health 8 (1982), suppl. 1 79-82
17. Challen, C., J. Lunée, W. Warren, J. Collier, and M. F. Bassedine: Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16 (1992)1362-1366
18. Chan, J. K. C., T. T. C. Yip, W. Y. W. Tsang, W.-H. Lau, C. S. C. Wong, and V. W. S. Ma: Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum. Pathol. 26 (1995) 314-318
19. Choi, S. W., P. Hytiroglou, S. A. Celler, S. M. Kirn, K. W. Chung, D. H. Park, N. D. Theise, and S. N. Thung: The expression of p53 antigen in primary malignant epithelial tumors of the liver: an immunohistochemical study. Liver 13 (1993) 172-176
20. Cohen, C. and P. B. DeRose: Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod. Pathol. 7 (1994) 536-539
21. Collier, J. D., M. Carpenter, A. D. Burt, and M. F. Bassendine: Expression of mutant p53 protein in hepatocellular carcinoma. Gut 35 (1994) 98-100
22. Consensus Report: Multistage and multifactorial nature of carcinogenesis. In: Vainio, H., P. N. Magee, D. B. McCregor, A. J. McMichael (eds.): Mechanisms of carcinogenesis in risk identification. IARC Scientific Publications No. 116. IARC, Lyon 1992, 9-54
23. Constantin, D., K. Mehrota, A. Rahimtula, P. Moldeus, and β. Jernström: Stimulatory effects of sulfar and nitrogen oxides on carcinogen activation in human polymorphonuclear leukocytes. Environ. Health Perspect. 102 (1994), suppl. 4, 161-164
24. Copper, M. P., A. Jovanovic, J. J. P. Nauta, B. J. M. Braakhuis, N. de Vries, I. fan der Waal, and G. B. Snow: Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 121 (1995), 157-160
25. D'Avanzo, B., E. Negri, C. La Veccbia, A. Gramenzi, C. Bianchi, S. Franceschi, and P. Boyle: Cigarette smoking and bladder cancer. Eur. J. Cancer 26 (1990), 714-718
26. De Benedetti, V. M. G., J. A. Welsh, G. E. Trivers, A. Harpster, A. J. Parkinson, A. P. Lanier, B. J. McMahon, and W. P. Bennett: p53 is not mutated in hepatocellular carcinomas from Alaska natives. Cancer Epidemiol. Biomark. Prevent. 4 (1995) 79-82
27. Debuire, B., P, Paterlini, P. Pontisso, G. Basso, and £. May: Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene 8 (1993) 23032306
28. Emmelin, A., L.Nystrom, and S. Wall: Diesel exhaust exposure and smoking: a case-referent study of lung cancer among Swedish dock workers. Epidemiology 4 (1993), 237244
29. Field, J. K.: Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol, Eur. J. Cancer 28B (1992) 67-76
30. Fraumeni, J. F.: Epidemiology of cancer. In: Brugge, J., T. Curran, E. Harlow, F. McCormick (eds.): Origins of human cancer. Cold Spring Harbor Laboratory Press, 1991 171-181
31. Fujimoto, Y., L. L. Hampton, P. J. Wirth, N. J. Wang, J. P. Xie, and 5. S. Thorgeirsson: Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 54 (1994) 281-285
32. Furihata, M., K. Inoue, Y. Ohtsuki, H. Hashimoto, N. Terao, and Y. Irujita: High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 53 (1993) 4823-4727
33. Galle, P. R., U. Räth, W. J. Hofmann, H. Zentgrafund M. Volkmann: Überexpression eines aberranten p53 beim hepatozellulären Karzinom nach Punktmutation des p53-Tumor-Suppressorgens. Inn. Vied. 19 (1992) 37-40
34. Gcrvasi, P. G., V. Longo, M. Marzano, M. Saviozzi, and G. Malvaldi: Chronic liver injury by thioaceramide and promotion of hepatic carcinogenesis. |. Cancer Res. Clin. Oncol. 115 (1989)29-35
35. Glovcr-Kerkviler, J.: Environmental assault on immunity. Environ. Health Perspect. 103 (1995)236-239
36. Goldblum,}. R., R. E. Bartos, K. A. Can, and T. S. Prank: Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am. J. Surg. Pathol. 17 (1993) 1244-1251
37. Gonzalez, C. A., G. Lôpez-Abente, M. Errezola, A. Escolar, E. Riboli, I. Izarzugaza, and M. Nebot: Occupation and bladder cancer in Spain: a multi-centre case-control study. Int. J. Epidemiol. 18 (1989) 569-577
38. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 15 (1994) 4855-4878
39. Habs, M. and D. Schmähl: Combination effects in different organs in small rodents. In: Schmahl, D.: Combination effects in chemical carcinogenesis. VCH, Weinheim 1988, 75-92
40. Hager, K. L, J. Böse-Landgraf, R. Häring, Y. Nishibe und K. Inoue: Wird das kolorektale Karzinom durch eine Virusinfektion ausgelöst? Dtsch. Med. Wschr. 120 (1995) 1145
41. Harris, C. C.: Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol. Biomark. Prevent 3 (1994) 1-2
42. Hasegawa, R., S. Takayama, and N. ho: Effects of low level exposure to multiple carcinogens in combination. In: Yang, R. S. H. (ed.): Toxicology of chemical mixtures. Academic Press, San Diego 1994, 361-382
43. Hayashi, H., K. Sugio, T. Matsumata, E. Adachi, K. Urata, S. Tanaka, and K. Sugimachi: The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma. Liver 13 (1993) 279-281
44. Hemminki, K.: DNA adducts, mutations and cancer. Carcinogenesis 14 (1993) 20072012
45. Henderson, B. E.: Establishment of an association between a virus and a human cancer. J. Nad. Cancer Inst. 81 (1989) 320-321
46. Hilt, B., S. Langard, A. Andersen, and J. Rosenberg: Asbestos exposure, smoking habits, and cancer incidence among production and maintenance workers in an electrochemical plant. Am. J. Ind. Med. 8 (1985) 565-577
47. Holder, J. W., E. Eltnore, and J. C. Barrett: Gap junction function and cancer. Cancer Res. 53 (1993)3475-3485
48. Hornung, R. W., J. Deadens, and R. Roscoe: Modifiers of exposure-response estimates for lung cancer among miners exposed to radon progeny. Environ. Health Perspect. 103 (1995)suppl. 2, 49-53
49. Hotz-Wagenblatt, A. and D. Sballoway: Gap junctional communication and neoplastic transformation. Crit. Rev. Oncogen. 4 (1993) 541-558
50. Hsia, C. C., D. E. Kleiner, C. A. Axiotis, A. D. Bisceglie, A. M. Y. Nomura, G. N. Stemmermann, and E. Tabor: Mutations of p53 genen in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J. Nad. Cancer Inst. 84 (1992) 1638-1641
51. Hsu, I. C., R. A. Metcalf, T. Sun, J. A. Welsh, N. J. Wang, and C. C. Harris: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350 (1991) 427-428
52. Hsu, H.-C., S.-Y. Peng, P.-L. Lai, J.-S. Chu, and P.-H. Lee: Mutations of p53 gene in hepatocellular carcinoma (HCC) correlate with tumor progression and patient prognosis: a study of 138 patients with unifocal HCC. Int. J. Oncol. 4 (1994) 1341-1347
53. Husgafvel-Pursiainen, K., P. Hackman, M. Ridanpää, S. Anttila, A. Karjalainen, T. Partanen, O. Taikina-Aho, L. Heikkilä, and H. Vainio: K-ras muations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer 53 (1993) 250-256
54. Husgafvel-Pursiainen, K., M. Ridanpää, S. Anttila, and H. Vainio: p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures. J. Occup. Environ. Med. 37 (1995) 69-76
55. IARC: IARC monographs on the evaluation of carcinogenic risks to humans. Occupational exposures to mists and vapours from strong inorganic acids; and other industrial chemicals. Volume 54. IARC, Lyon 1992
56. Ishimaru, T., H. Okada, T. Tomiyasu, T. Tsuchimoto, T. Hoshino, and M. Ichimaru: Occupational factors in the epidemiology of leukemia in Hiroshima and Nagasaki. Am. J. Epidemiol. 93 (1971) 157-165
57. Jedrychowski, W., H. Becher, J. Wahrendorf, and Z. Basa-Cierpialek: A case-control study of lung cancer with special reference to the effect of air pollution in Poland. J. Epidemiol. Comm. Health 44 (1990) 114-120
58. Jobling, S., T. Reynolds, R. White, M. G. Parker, andJ. P. Sumpter: A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103 (1995) 582-587
59. Kaiser. R.: Östrogene und Karzinom. Dtsch. Med. Wschr. 114 (1989) 637-643
60. Kehrer, G.: Zur medizinischen Bedeutung von Gap junctions. Med. Klin. 89 (1994) 255-261
61. Kenne, K., R. Fransson-Steen, S. Honkasalo, and L. Wärngard: Two inhibitors of gap junctional intercellular communication, TPA and endosulfan: different effects on phosphorylation of connexin 43 in the rat liver epithelial cell line, IAR 20. Carcinogenesis 15(1994)1161-1165
62. Koch, K.: Hepres-Viren jetzt nachgewiesen. Dt. Ärztebl. 92 (1995) C-208
63. L'Abbé, K. A., G. R. Howe, J. D. Burch, A. B. Miller, j. Abhält, P. Band, W. Choi, J. Du, J. Feather, R. Gallagher, G. Hill, and V. Matthews: Radon exposure, cigarette smoking, and other mining experience in the Beaverlodge uranium miners cohort. Health Physics 60 (1991 (489-495
64. Laurent-Puig, P., J.-F. Flejou, M. Fahre, P. Bedossa, J. Belghiti, F. Gayral, and D. Franco: Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 16 (1992) 1171-1175
65. Lewtas, J., L. C. King, and D. M. DeMarini: New approaches to bioassay- and biomarker-directed identification of genotoxic components in complex mixtures: DNA adduct identification and mutation spectra. In: Yang, R. S. H (ed.): Toxicology of chemical mixtures. Academic Press, San Diego 1994, 385-398
66. LiJ.J.: Hormonal carcinogenesis. Cancer Cells 3 (1991) 318-321
67. Li, D., Y. Cao, L. He, N. J. Wang, and J. R. Gu: Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 14 (1993) 169-173
68. London, N. J., S. M. Farmery, E. J. Will, A. M. Davison, and J. P. A. Lodge. Risk of neoplasia in renal transplant patients. Lancet 346 (1995) 403-406
69. Luder, G. W.: Receptor-mediated carcinogenesis. In: Vainio, H., P. N. Magee, D. B. McGregor, A. J. McMichael (eds.): Mechanisms of carcinogenesis in risk identification. IARC Scientific Publications No. 116. IARC, Lyon 1992, 87-112
70. Maier, H. und E. Sennewald: Plattenepithelkarzinome. HVBG, St. Augustin 1994
71. Mirsalis, J. C., K. L. Steinmetz, C. M. Hamilton,J. P. Bakke, and K. E. Garin: The rôle of cell proliferation in chemical carcinogenesis. In: Mutation and the environment. Part D. Wiley, New York 1990, 113-122
72. Moeller, H. and P. Correa: Carcinogenicity of some biological agents. Cancer Epidemiol. Biomark. Prevent. 3 (1994) 627'
73. Morimoto, H., T. Ueda, T. Hiyama, N. Hosono, S. Mori, and Y. Komatsubara: The risk of cancer in rheumatoid patients in Japan. Scand. J. Rheumatol. 24 (1995) 157-159
74. Morris, J. D. H., A. L. W. Eddleston, and T. Crook: Viral infection and cancer. Lancet 346(1995) 754-758
75. Nagao, T., F. Kondo, T. Sato, Y. Nagato, and Y. Kondo: Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma. Hum. Pathol. 26 (1995) 326-333
76. Ng, I. O. L., L. P. Chung, S. W. Y. Tsang, C. L. Lam, E. C. S. Lai, S. T. Fan, and M. Ng: p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene 9 (1994) 985-990
77. Nishida, N., Y. Fukuda, H. Kokuryu, J. Toguchida, D. W. Yandell, M. Ikenega, H. Imura, and K. Ishizaki: Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res. 53 (1993) 368-372
78. Nishida, N., Y. Fukuda, and K. Ishizaki: Molecular aspects of hepatocarcinogenesis and their clinical implications (review). Int. J. Oncol. 4 (1994) 615-622
79. Nose, H., F. Imazeki, M. Ohto, and M. Omata: p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma form Japan. Cancer 72 (1993) 355-360
80. Ozturk, M. and collaborators: p53 mutation in hepatocellular carcinoma after aflatoxm exposure. Lancet 338 (1991) 1356-1359
81. Pankow, D., I. Grimm, R. Gutewort, E. Rosenfeld, P. Schmidt und D. L. Wolff: Kombinationswirkung von Ethanol und Lösungsmitteln. Z. gesamte Hyg. 31 (1985) 338343
82. Pershagen, G., G. Akerblom, O. Axelson, B. Calvensjö, L. Damber, G. Desai, A. Enflo, F. Lagarde, H. Meilander, M. Svartengren, and G. A. Swedjemark: Residential radon exposure and lung cancer in Sweden. N. Engl. J. Med. 330 (1994) 159-164
83. Popp, W., C. Schell, R. Kraus, C. Vahrenholz, R. Wolf, }. Radtke, K. Bierwirth, and K. Norpoth: DNA strand breakage and DNA adducts in lymphocytes of oral cancer patients. Carcinogenesis 14 (1993) 2251-2256
84. Popp, W., R. Wolf, C. Vahrenholz, J. Radtke, C. Schell, R. Kraus, A. Brauksiepe, and K. Norpoth: Sister chromatid exchange frequencies in lymphocytes of oral cancer patients seem to be influenced by drinking habits. Carcinogenesis 15 (1994) 1603-1607
85. Popp, W.: Zum Krebsrisiko auf Kokereien - Epidemiologie, Gefahrstoffexpositionen, derzeitige Überwachungsstrategien und neue Möglichkeiten der Molekularen Epidemiologie. Habilitationsschrift, Essen 1995
86. Ray, P. K., K. P. Singh, R. Prasad, and A. K. Prasad: Immunological responses to aflatoxins and other chemcial carcinogens. J. ToxicoL- Toxin Rev. 10 (1991) 63-85
87. Ren, P., A. W. de Feifter, D. L. Paul, and R. J. Ruch: Enhancement of liver cell gap junction protein expression by glucocorticoids. Carcinogenesis 15 (1994) 1807-1813
88. Rosier, J. A., H.-J. Lange und R. H. Woitowitz: Asbesteinwirkung am Arbeitsplatz und Sterblichkeit and bösartigen Tumoren in der Bundesrepublik Deutschland. Forschungsbereicht Asbest IV. HVBG, St. Augustin 1993
89. Rüdiger, H. W. und D. Nowak: Bronchialkarzinom. Internist 35 (1994) 700-709
90. Rüther, U., C. Nunnensiek, H. A. G. Müller, B. Rothe, J. Dohbertin, H. Bader, P. Jipp, and H. Toomes: Evidence of EBV-, HSV(I+II)-, HHV6-, CMV-DNA, and adenovirus 2E1A and 5E1B in mucous membrane of bronchogenic carcinoma, pleural mesothelioma, sarcoidosis, and intrinsic asthma. Tumordiagn. Then 15 (1994) 121-127
91. Seitz, H.K. und U.A.Simanowski: Beziehung zwischen Alkoholkonsum und Krebserkrankungen. Dt. Ärtzebl. 83 (1986) C-254-255
92. Seitz, H. K., U. A. Simanowski und F. T. Garzon: Alkohol und Karzinogenese. Ernährungs-Umschau 34 (1987) 120-126
93. Selig, R., R. Pabst und J. Mehlhorn: Der Einfluβ des Rauchens auf die Erkrankungsinzidenz am Schneeberger Lugenkrebs" und Aussagen zum aktuellen Erkrankungsrisiko bei männlichen Beschäftigten der ehemaligen SDAG Wismut. In: Kreutz, R., C. Piekarski (Hrsg.): Bericht über die 32. Jahrestagung der Deutschen Gesellschaft für Arbeitsmedizin e.V. Gentner, Stuttgart 1992, 407-412
94. Selikoff, l. )., E. C. Hammond, and J. Churg: Asbestos exposure, smoking, and neoplasia. JAMA 204 (1968) 104-110
95. Selikoff, I. J., H. Seidman, and E. C. Hammond: Mortality effects of cigarette smoking among amosite asbestos factory workers. JNCI 65 (1980) 507-513
96. Stickney, ], A., D. M. Silverman, and R. A. Schatz: Role of isozyme-specific inhibition of cytochrome P450IIB1 activity in m-xylene-induced alterations in rat pulmonary benzo(a)pyrene metabolism. Xenobiotica 21 (1991) 641-649
97. Swierenga, S. H. H. and H. Yamasaki: Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. In: Vainio, H., P. N. Magee, D. B. McGregor, A. J. McMichael (eds.): Mechanisms of carcinogenesis in risk identification. IARC Scientific Publications No. 116. IARC, Lyon 1992, 165-192
98. Tanaka, S., Y. Toh, E. Adachi, T. Matsumata, R. Mon', and K. Sugimachi: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res. 53 (1993)2884-2887
99. Taylor, G. N., R. D. Lloyd, C. W. Mays, L. Shabestari, and S. C. Miller: Promotion of radiation-induced liver neoplasia by ethanol. Health Phys. 62 (1992) 178-182
100. Teramoto, T., K. Satonaka, S. Kitazawa, T. Fu/imori, K. Hayashi, and S. Maeda: p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res. 54 (1994) 231-235
101. Tuyns, A.J.: Alcohol and cancer. Proc. Nutr. Soc. 49 (1990) 145-151
102. Vainio, H. and P. Boffetta: Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand. J. Work Environ. Health 20 (1994) 235-242
103. Vainio, H., K. Husgafvel-Pursiainen, S. Anttila, A. Karjalainen, P. Hackman, and T.Partanen: Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations. Environ. Health Perspect. 101 (1993), suppl. 3, 189-192
104. Vineis, P., B. Terracini, G. Costa, F. Merletti, and N. Segnan: Interaction between occupational risks and cigarette smoking in bladder cancer: a case-control study. In: ILO: Prevention of occupational cancer - International Symposium. Occupational Safety and Health Series No. 46. Geneva 1982, 327-331
105. Volkmann, M., W. J. Hofmann, M. Müller, U. Räth, G. Otto, H. Zentgraf, and P. R. Galle: p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9 (1994) 195-204
106. Wang, X., D. C. Christiani, J. K. Wiencke, M. Fischbein, X. Xu, T.J. Gheng, E. Mark, J. C. Wain, and K. T. Kelsey: Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol. Biomark. Prevent 4 (1995)543-548
107. Westra, W. H., R. J. C. Slebos, G. J. A. Offerhaus, S. N. Goodman, S. G. Evers, T. W. Kensler, F. B. Askin, S. Rodenhuis, and R. H. Hruban: K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer 72 (1993) 432-438
108. Wild, C. P., S. M. Shrestha, W. A. Anwar, and R. Montesano: Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand. Toxicol. Lett. 64/ 65(1992)455-461
109. Wu, W.: Occupational cancer epidemiology in the People's Republic of China. J. Occup. Med. 30 (1988) 968-974
110. Zeller, W. J, and M. R. Berger: Combination effects of tobacco constituents in experimental carcinogenesis. In: Scbmähl, D.: Combination effects in chemical carcinogenesis. VCH, Weinheim 1988, 175-191
111. zur Hausen, H.: Viruses in human cancers. Science 254 (1991) 1167-1173
112. 112.zur Hausen, H.: Krebsentstehung durch Infektionen - ein wichtiger, noch wenig beachteter Sektor der Krebsforschung. Dt. Ärztebl. 91 (1994) A-738-740